American Century Companies Inc Scholar Rock Holding Corp Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.2 - $17.76 $615,529 - $828,166	-46,631 Reduced 78.66%	12,650 $224,000
Q4 2023 Feb 13, 2024	BUY	$6.52 - $20.32 $386,512 - $1.2 Million	59,281 New	59,281 $1.11 Million
Q3 2023 Nov 13, 2023	BUY	$6.02 - $7.76 $39,358 - $50,734	6,538 Added 31.09%	27,570 $195,000
Q2 2023 Aug 14, 2023	BUY	$5.79 - $9.11 $39,429 - $62,039	6,810 Added 47.88%	21,032 $158,000
Q1 2023 May 11, 2023	BUY	$7.36 - $12.72 $28,071 - $48,514	3,814 Added 36.64%	14,222 $113,000
Q4 2022 Feb 13, 2023	BUY	$7.02 - $9.76 $73,064 - $101,582	10,408 New	10,408 $94,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.